Jessica Cerullo is a dedicated and passionate Senior Director of Patient Advocacy & Disease States Initiatives at Pierre Fabre Pharmaceuticals. With over a decade of experience in the pharmaceutical industry, Jessica has established herself as a leader in advocating for patients with rare diseases. Her commitment to improving the lives of those affected by orphan diseases is evident in her strategic initiatives and partnerships with patient advocacy groups.
Jessica's expertise lies in developing comprehensive programs that support patients throughout their treatment journey. She works closely with healthcare professionals, researchers, and policymakers to ensure that patients have access to innovative therapies and quality care. Her collaborative approach has led to the successful implementation of patient-centric solutions that address the unique challenges faced by individuals with rare diseases.
At Pierre Fabre Pharmaceuticals, Jessica plays a pivotal role in driving the company's mission to advance orphan drug development and improve patient outcomes. She is known for her strong advocacy for rare disease awareness and her ability to mobilize stakeholders towards a common goal. Jessica's leadership and dedication have earned her recognition as a key opinion leader in the orphan drug community.
As a speaker at the World Orphan Drug Congress USA 2026, Jessica Cerullo will share her insights and experiences in patient advocacy and disease states initiatives. Her expertise and passion for making a difference in the lives of those with rare diseases make her a valuable asset to the conference. Attendees can expect to gain valuable knowledge and inspiration from Jessica's presentation, as she continues to drive positive change in the orphan drug landscape.